Michael Petusky
Stock Analyst at Barrington Research
(2.07)
# 3,022
Out of 4,996 analysts
203
Total ratings
35%
Success rate
-3.79%
Average return
Main Sectors:
Stocks Rated by Michael Petusky
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Maintains: Outperform | $17 | $14.29 | +18.96% | 2 | Sep 23, 2025 | |
| OPCH Option Care Health | Maintains: Outperform | $38 | $27.30 | +39.19% | 17 | Sep 23, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $103 | $80.20 | +28.43% | 22 | Sep 23, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Outperform | $95 | $84.19 | +12.84% | 12 | Sep 23, 2025 | |
| HSIC Henry Schein | Maintains: Outperform | $78 | $66.04 | +18.11% | 16 | Sep 23, 2025 | |
| HAE Haemonetics | Maintains: Outperform | $86 | $48.17 | +78.53% | 31 | Sep 23, 2025 | |
| ANIK Anika Therapeutics | Maintains: Outperform | $15 | $9.01 | +66.48% | 19 | Sep 23, 2025 | |
| VRME VerifyMe | Maintains: Outperform | $1.25 → $1.5 | $0.92 | +63.81% | 10 | Aug 14, 2025 | |
| SRDX Surmodics | Reiterates: Market Perform | n/a | $29.95 | - | 7 | Aug 11, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Outperform | $21 → $18 | $12.50 | +44.00% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $98 → $103 | $83.40 | +23.50% | 24 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $2.25 | $1.45 | +55.17% | 14 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $7.01 | - | 6 | Aug 28, 2024 |
Orthofix Medical
Sep 23, 2025
Maintains: Outperform
Price Target: $17
Current: $14.29
Upside: +18.96%
Option Care Health
Sep 23, 2025
Maintains: Outperform
Price Target: $38
Current: $27.30
Upside: +39.19%
Merit Medical Systems
Sep 23, 2025
Maintains: Outperform
Price Target: $103
Current: $80.20
Upside: +28.43%
LeMaitre Vascular
Sep 23, 2025
Maintains: Outperform
Price Target: $95
Current: $84.19
Upside: +12.84%
Henry Schein
Sep 23, 2025
Maintains: Outperform
Price Target: $78
Current: $66.04
Upside: +18.11%
Haemonetics
Sep 23, 2025
Maintains: Outperform
Price Target: $86
Current: $48.17
Upside: +78.53%
Anika Therapeutics
Sep 23, 2025
Maintains: Outperform
Price Target: $15
Current: $9.01
Upside: +66.48%
VerifyMe
Aug 14, 2025
Maintains: Outperform
Price Target: $1.25 → $1.5
Current: $0.92
Upside: +63.81%
Surmodics
Aug 11, 2025
Reiterates: Market Perform
Price Target: n/a
Current: $29.95
Upside: -
DENTSPLY SIRONA
Aug 8, 2025
Maintains: Outperform
Price Target: $21 → $18
Current: $12.50
Upside: +44.00%
Aug 8, 2025
Maintains: Outperform
Price Target: $98 → $103
Current: $83.40
Upside: +23.50%
May 1, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.45
Upside: +55.17%
Aug 28, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $7.01
Upside: -